Clinical Trials for iBio

Explore 24 clinical trials worldwide

Showing 1-24 of 24 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: iBio

Clinical Trials (24)

NCT07150416
Nebulized Inhalation of Recombinant Human p53 Adenovirus Injection for Treatment of Multiple Ground-Glass Lung Nodules: A Single-Arm Clinical Study
PHASE2Not yet recruiting
38 participants
Started: Oct 1, 2025 · Completed: Feb 1, 2027
3 conditions2 sponsors1 location
NCT07159360
Safety, Usability, and Effectiveness of a Gait Exoskeleton for Children and Adolescents With Neurodevelopmental Disorders.
NANot yet recruiting
60 participants
Started: Sep 15, 2025 · Completed: Jun 1, 2026
2 conditions3 sponsors2 locations
NCT07062198
Combined Metabolic Activator Supplementation in Subjects Diagnosed With Alzheimer's Disease
PHASE3Recruiting
845 participants
Started: Sep 12, 2025 · Completed: Sep 30, 2026
1 condition1 sponsor9 locations
NCT06919354
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
PHASE1Recruiting
16 participants
Started: Sep 3, 2025 · Completed: Feb 29, 2028
2 conditions1 sponsor9 locations
NCT06470373
A Phase 3 Clinical Trial to Compare RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular Degeneration
PHASE3Not yet recruiting
434 participants
Started: Jul 31, 2025 · Completed: Sep 30, 2026
1 condition1 sponsor7 locations
NCT06894160
Safety and Usability of the EXPLORER Exoskeleton in Adults With Neuromuscular Diseases
NANot yet recruiting
7 participants
Started: Jul 1, 2025 · Completed: Aug 1, 2025
1 condition2 sponsors1 location
NCT06552169
REgulatory T Cell Therapy to Achieve Immunosuppression REduction
PHASE2Recruiting
34 participants
Started: Jun 13, 2025 · Completed: Jun 30, 2031
1 condition3 sponsors4 locations
NCT06860516
HLA Demographics Study in Adults With Type 1 Diabetes
N/ARecruiting
50 participants
Started: Jun 6, 2025 · Completed: Jun 30, 2026
1 condition1 sponsor5 locations
NCT07024407
A Study of Andecaliximab in People With Spinal Cord Injury at Risk for Bone Growth Outside of the Normal Skeleton.
PHASE1/PHASE2Recruiting
10 participants
Started: May 14, 2025 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06765070
Efficacy and Usability of the EXPLORER Exoskeleton in Children With Neurodevelopmental Disorders in Natural Environments
NAActive, not recruiting
15 participants
Started: Mar 1, 2025 · Completed: Dec 1, 2025
2 conditions6 sponsors6 locations
NCT06772077
Safety and Usability of the ATLAS 2030 Exoskeleton in Pediatric Patients With Spinal Cord Injury
NARecruiting
20 participants
Started: Feb 17, 2025 · Completed: Feb 1, 2026
1 condition3 sponsors1 location
NCT06566157
PROMOTE: The Effect of a Six Week Prebiotic Supplementation on Wellbeing of Young Adults.
NANot yet recruiting
70 participants
Started: Jan 6, 2025 · Completed: Sep 16, 2026
3 conditions2 sponsors1 location
NCT06508021
A Study of Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)
PHASE2/PHASE3Active, not recruiting
92 participants
Started: Oct 25, 2024 · Completed: Feb 4, 2029
1 condition1 sponsor3 locations
NCT06585267
Development of a New Patient Reported Outcome Measure (PROM) to Assess Patient's Emotional Wellbeing, and Perceptions of Total Knee Replacement Surgery for the Treatment of Knee Arthritis
N/ARecruiting
150 participants
Started: Oct 7, 2024 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06196528
WristArt Total Wrist Arthroplasty Implant First In Human Study
NARecruiting
5 participants
Started: Jan 2, 2024 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT06537076
Safety and Efficacy of AR1005 in Patients with Lewy Body Disease
PHASE2Recruiting
60 participants
Started: Jan 1, 2024 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT06263517
Clinical Trial to Assess Efficacy, Tolerability of Rising Doses of Clodronate in Painful Knee Osteoarthritis Patients
PHASE2/PHASE3Recruiting
296 participants
Started: Oct 12, 2023 · Completed: Oct 31, 2025
1 condition2 sponsors11 locations
NCT05926635
Efficacy of a Rehabilitation Program With the Pediatric Exoskeleton ATLAS 2030 in Pediatric Patients With Cerebral Palsy
N/AActive, not recruiting
60 participants
Started: Aug 3, 2023 · Completed: May 11, 2025
1 condition6 sponsors5 locations
NCT05789069
A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
PHASE1Recruiting
83 participants
Started: May 9, 2023 · Completed: Dec 31, 2025
5 conditions1 sponsor11 locations
NCT05631392
Study to Evaluate the Clinical and Radiographic Outcomes of the BEE® HA Cage for Anterior Cervical Discectomy and Fusion
N/ARecruiting
51 participants
Started: Feb 3, 2023 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT05531526
Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)
PHASE3Active, not recruiting
1,535 participants
Started: Dec 23, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor198 locations
NCT05238883
A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
PHASE1Recruiting
170 participants
Started: Mar 10, 2022 · Completed: Dec 31, 2026
9 conditions1 sponsor10 locations
NCT04416321
A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced.
NARecruiting
30 participants
Started: Jul 1, 2021 · Completed: Jan 31, 2026
3 conditions5 sponsors1 location
NCT05589493
Hybrid PEEK-Acrylic Resin Prostheses and the All-on-4 Concept for Full-Arch Rehabilitation - Routine Group
NAActive, not recruiting
39 participants
Started: Nov 13, 2017 · Completed: Jul 31, 2026
1 condition2 sponsors1 location